Why is Brooks Lab. falling/rising?

As of 22-Jul, Brooks Laboratories Ltd is experiencing a decline in its stock price, currently at 157.05, which reflects a decrease of 2.65 or 1.66%. Despite this drop, the stock has shown strong performance over the past month, with a return of 20.81%, significantly outperforming the Sensex, which has decreased by 0.27%. Additionally, the stock is trading above its moving averages across various time frames, indicating a generally positive trend. However, it has underperformed its sector by 0.75% today and has exhibited high volatility, with an intraday volatility of 217.55%. The rising investor participation, with a delivery volume increase of 22.21% against the 5-day average, suggests a growing interest in the stock, although no specific positive or negative factors were provided to explain the recent price movement.
Broader Market Context: In the short term, Brooks Laboratories Ltd has outperformed the benchmark Sensex over the past week, gaining 1.98% compared to the benchmark's decline of 0.47%. However, on a year-to-date basis, the stock has underperformed the Sensex, which has risen by 5.18%, with Brooks Laboratories showing a decline of 15.09%. This contrast highlights the stock's recent volatility and the challenges it faces despite its strong long-term performance, which includes an impressive 86.85% increase over the past year compared to the Sensex's modest 2.09% gain.